Unknown

Dataset Information

0

Guidance for the practical management of the direct oral anticoagulants (DOACs) in VTE treatment.


ABSTRACT: Venous thromboembolism (VTE) is a serious medical condition associated with significant morbidity and mortality, and an incidence that is expected to double in the next forty years. The advent of direct oral anticoagulants (DOACs) has catalyzed significant changes in the therapeutic landscape of VTE treatment. As such, it is imperative that clinicians become familiar with and appropriately implement new treatment paradigms. This manuscript, initiated by the Anticoagulation Forum, provides clinical guidance for VTE treatment with the DOACs. When possible, guidance statements are supported by existing published evidence and guidelines. In instances where evidence or guidelines are lacking, guidance statements represent the consensus opinion of all authors of this manuscript and are endorsed by the Board of Directors of the Anticoagulation Forum.The authors of this manuscript first developed a list of pivotal practical questions related to real-world clinical scenarios involving the use of DOACs for VTE treatment. We then performed a PubMed search for topics and key words including, but not limited to, apixaban, antidote, bridging, cancer, care transitions, dabigatran, direct oral anticoagulant, deep vein thrombosis, edoxaban, interactions, measurement, perioperative, pregnancy, pulmonary embolism, reversal, rivaroxaban, switching, \thrombophilia, venous thromboembolism, and warfarin to answer these questions. Non- English publications and publications > 10 years old were excluded. In an effort to provide practical information about the use of DOACs for VTE treatment, answers to each question are provided in the form of guidance statements, with the intent of high utility and applicability for frontline clinicians across a multitude of care settings.

SUBMITTER: Burnett AE 

PROVIDER: S-EPMC4715848 | BioStudies | 2016-01-01T00:00:00Z

SECONDARY ACCESSION(S): NCT02207725

REPOSITORIES: biostudies

Similar Datasets

2015-01-01 | S-EPMC4501448 | BioStudies
2018-01-01 | S-EPMC6046599 | BioStudies
2018-01-01 | S-EPMC6058321 | BioStudies
2016-01-01 | S-EPMC4884797 | BioStudies
1000-01-01 | S-EPMC4715846 | BioStudies
2019-01-01 | S-EPMC6714910 | BioStudies
2019-01-01 | S-EPMC6593743 | BioStudies
2017-01-01 | S-EPMC5490483 | BioStudies
1000-01-01 | S-EPMC5581345 | BioStudies
2015-01-01 | S-EPMC4654552 | BioStudies